Stocks
Funds
Screener
Sectors
Watchlists

Latest COMMODORE CAPITAL LP Stock Portfolio

COMMODORE CAPITAL LP Performance:
2024 Q3: 7.86%YTD: 34.19%2023: 31.13%

Performance for 2024 Q3 is 7.86%, and YTD is 34.19%, and 2023 is 31.13%.

About COMMODORE CAPITAL LP and 13F Hedge Fund Stock Holdings

COMMODORE CAPITAL LP is a hedge fund based in NEW YORK, NY. On 24-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $814.6 Millions. In it's latest 13F Holdings report, COMMODORE CAPITAL LP reported an equity portfolio of $1.6 Billions as of 30 Sep, 2024.

The top stock holdings of COMMODORE CAPITAL LP are MRUS, VERA, XENE. The fund has invested 10.5% of it's portfolio in MERUS N V and 6.8% of portfolio in VERA THERAPEUTICS INC.

The fund managers got completely rid off IMMUNOVANT INC (IMVT), AUTOLUS THERAPEUTICS PLC (AUTL) and ARCA BIOPHARMA INC (ABIO) stocks. They significantly reduced their stock positions in RHYTHM PHARMACEUTICALS INC (RYTM), NUVALENT INC (NUVL) and ARVINAS INC (ARVN). COMMODORE CAPITAL LP opened new stock positions in NURIX THERAPEUTICS INC (NRIX), ORUKA THERAPEUTICS INC and CENTESSA PHARMACEUTICALS PLC (CNTA). The fund showed a lot of confidence in some stocks as they added substantially to AVALO THERAPEUTICS INC (AVTX), ALKERMES PLC (ALKS) and CELLDEX THERAPEUTICS INC NEW (CLDX).

COMMODORE CAPITAL LP Annual Return Estimates Vs S&P 500

Our best estimate is that COMMODORE CAPITAL LP made a return of 7.86% in the last quarter. In trailing 12 months, it's portfolio return was 70.61%.

New Buys

Ticker$ Bought
nurix therapeutics inc37,075,500
oruka therapeutics inc33,571,700
centessa pharmaceuticals plc21,586,500
instil bio inc10,160,500

New stocks bought by COMMODORE CAPITAL LP

Additions to existing portfolio by COMMODORE CAPITAL LP

Reductions

Ticker% Reduced
rhythm pharmaceuticals inc-46.94
nuvalent inc-36.82
arvinas inc-36.32
vaxcyte inc-29.5
perspective therapeutics inc-28.07
cogent biosciences inc-22.57
third harmonic bio inc-11.96
soleno therapeutics inc-11.58

COMMODORE CAPITAL LP reduced stake in above stock

Sold off

Ticker$ Sold
autolus therapeutics plc-4,101,960
immunovant inc-19,826,100
arca biopharma inc-1,586,860

COMMODORE CAPITAL LP got rid off the above stocks

Sector Distribution

COMMODORE CAPITAL LP has about 82.7% of it's holdings in Healthcare sector.

Sector%
Healthcare82.7
Others17.3

Market Cap. Distribution

COMMODORE CAPITAL LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP47.2
SMALL-CAP34.7
UNALLOCATED17.3

Stocks belong to which Index?

About 51.7% of the stocks held by COMMODORE CAPITAL LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200051.7
Others48.3
Top 5 Winners (%)%
TIL
instil bio inc
426.4 %
VRDN
viridian therapeutics inc
74.6 %
ORIC
oric pharmaceuticals inc
45.0 %
PCVX
vaxcyte inc
38.6 %
CNTA
centessa pharmaceuticals plc
27.9 %
Top 5 Winners ($)$
PCVX
vaxcyte inc
38.0 M
NUVL
nuvalent inc
28.1 M
VRDN
viridian therapeutics inc
24.8 M
COGT
cogent biosciences inc
20.3 M
VERA
vera therapeutics inc
19.8 M
Top 5 Losers (%)%
CABA
cabaletta bio inc
-36.9 %
NKTX
nkarta inc
-22.6 %
MNMD
mind medicine mindmed inc
-20.2 %
MRUS
merus n v
-15.1 %
CELC
celcuity inc
-9.0 %
Top 5 Losers ($)$
MRUS
merus n v
-29.7 M
MNMD
mind medicine mindmed inc
-11.5 M
NKTX
nkarta inc
-6.2 M
CLDX
celldex therapeutics inc new
-4.9 M
ARVN
arvinas inc
-3.0 M

COMMODORE CAPITAL LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of COMMODORE CAPITAL LP

COMMODORE CAPITAL LP has 36 stocks in it's portfolio. About 60.8% of the portfolio is in top 10 stocks. MRUS proved to be the most loss making stock for the portfolio. PCVX was the most profitable stock for COMMODORE CAPITAL LP last quarter.

Last Reported on: 14 Nov, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions